Erdur, A.C.* ; Scholz, D.* ; Nguyen, Q.M.* ; Buchner, J.A.* ; Mayinger, M.* ; Christ, S.M.* ; Brunner, T.B.* ; Wittig, A.* ; Zimmer, C.* ; Meyer, B.* ; Guckenberger, M.* ; Andratschke, N.* ; El Shafie, R.A.* ; Debus, J.U.* ; Rogers, S.* ; Riesterer, O.* ; Schulze, K.* ; Feldmann, H.J.* ; Blanck, O.* ; Zamboglou, C.* ; Bilger-Z, A.* ; Grosu, A.L.* ; Wolff, R.* ; Eitz, K.A. ; Combs, S.E. ; Bernhardt, D.* ; Wiestler, B.* ; Rueckert, D.* ; Peeken, J.C.
     
    
        
Improving risk assessment of local failure in brain metastases patients using vision transformers - A multicentric development and validation study.
    
    
        
    
    
        
        Radiother. Oncol. 210:111031 (2025)
    
    
    
      
      
	
	    BACKGROUND AND PURPOSE: This study investigates the use of Vision Transformers (ViTs) to predict Freedom from Local Failure (FFLF) in patients with brain metastases using pre-operative MRI scans. The goal is to develop a model that enhances risk stratification and informs personalized treatment strategies. MATERIALS AND METHODS: Within the AURORA retrospective trial, patients (n = 352) who received surgical resection followed by post-operative stereotactic radiotherapy (SRT) were collected from seven hospitals. We trained our ViT for the direct image-to-risk task on T1-CE and FLAIR sequences and combined clinical features along the way. We employed segmentation-guided image modifications, model adaptations, and specialized patient sampling strategies during training. The model was evaluated with five-fold cross-validation and ensemble learning across all validation runs. An external, international test cohort (n = 99) within the dataset was used to assess the generalization capabilities of the model, and saliency maps were generated for explainability analysis. RESULTS: We achieved a competent C-Index score of 0.7982 on the test cohort, surpassing all clinical, CNN-based, and hybrid baselines. Kaplan-Meier analysis showed significant FFLF risk stratification. Saliency maps focusing on the BM core confirmed that model explanations aligned with expert observations. CONCLUSIO: Our ViT-based model offers a potential for personalized treatment strategies and follow-up regimens in patients with brain metastases. It provides an alternative to radiomics as a robust, automated tool for clinical workflows, capable of improving patient outcomes through effective risk assessment and stratification.
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
    
        Thesis type
        
    
 
    
        Editors
        
    
    
        Keywords
        Artificial Intelligence ; Brain Metastases ; Stereotactic Radiotherapy ; Vision Transformers; Stereotactic Radiosurgery
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2025
    
 
    
        Prepublished in Year
        0
    
 
    
        HGF-reported in Year
        2025
    
 
    
    
        ISSN (print) / ISBN
        0167-8140
    
 
    
        e-ISSN
        1879-0887
    
 
    
        ISBN
        
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 210,  
	    Issue: ,  
	    Pages: ,  
	    Article Number: 111031 
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            Elsevier
        
 
        
            Publishing Place
            Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        Peer reviewed
    
 
     
    
        POF-Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Research field(s)
        Radiation Sciences
    
 
    
        PSP Element(s)
        G-501300-001
    
 
    
        Grants
        Deutsche Forschungsgemeinschaft (DFG, German Research foundation)
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2025-07-16